The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Radiotherapy and Oncology

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2011.02.010PMID 21429609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

  2010cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer.

  2010cited by this paper
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

  2010cited by this paper
• The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.

  2010cited by this paper
• Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

  2010cited by this paper
• Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications

  2009cited by this paper
• Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.

  2009cited by this paper
• 19LBA HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials

  2009cited by this paper
• Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients

  2009cited by this paper
• Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

  2009cited by this paper
• HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma

  2009cited by this paper
• Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

  2008cited by this paper
• Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

  2008cited by this paper
• EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

  2008cited by this paper
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

  2008cited by this paper
• Human papillomavirus in HNSCC: a European epidemiologic perspective.

  2008cited by this paper
• A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

  2007cited by this paper
• Case-control study of human papillomavirus and oropharyngeal cancer.

  2007cited by this paper
• The incidence of tonsillar cancer in Sweden is increasing

  2007cited by this paper
• Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer

  2006cited by this paper
• Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

  2006cited by this paper
• High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

  2006cited by this paper
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  2006cited by this paper
• Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

  2005cited by this paper
• The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.

  2005cited by this paper
• Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

  2005cited by this paper
• Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.

  2004cited by this paper
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

  2003cited by this paper
• Human papillomavirus immortalization and transformation functions.

  2002cited by this paper
• Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

  2000cited by this paper
• A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

  1998cited by this paper
• High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.

  1996cited by this paper
• The hazard of accelerated tumor clonogen repopulation during radiotherapy.

  1988cited by this paper

• Identification of a 32-gene signature that determines HPV status in head and neck cancer.

  2026cites this paper
• Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial.

  2026cites this paper
• Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986–2020

  2025cites this paper
• Treatment outcomes for human papillomavirus negative oropharyngeal cancer: A meta-analysis.

  2025cites this paper
• Long-term outcomes of consecutive patients of oropharyngeal cancer treated with radical radiotherapy

  2025cites this paper
• Significance of p16 in Site-Specific Human Papillomavirus-Positive and Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

  2024cites this paper
• Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

  2024cites this paper
• Hypofractionated radiation therapy alone for human papillomavirus‐related oropharyngeal cancer

  2024cites this paper
• PrimPol-mediated repriming elicits gap-filling by template switching and promotes cellular tolerance to cidofovir.

  2024cites this paper
• De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: Who, why, what, where, when, how, how much…and what next?

  2024cites this paper
• The emerging role of sentinel lymph node biopsy in oral cavity and oropharyngeal carcinomas

  2024cites this paper
• Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors

  2023cites this paper
• Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma

  2023cites this paper
• A review of diffusion-weighted magnetic resonance imaging in head and neck cancer patients for treatment evaluation and prediction of radiation-induced xerostomia

  2023cites this paper
• Incidence and characteristics of human papillomavirus-positive oropharyngeal cancers by p16 expression

  2022cites this paper
• The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Updates in the management of unknown primary of the head and neck

  2022cites this paper
• Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010–2016

  2022cites this paper
• Human Papillomavirus-Associated Head and Neck Cancers. Where are We Now? A Systematic Review

  2022cites this paper
• CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.

  2022cites this paper
• Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy.

  2022cites this paper
• Treatment de‐escalation for HPV+ oropharyngeal cancer: A systematic review and meta‐analysis

  2022cites this paper
• Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer

  2021cites this paper
• Why De-Intensification is not Possible in HPV-Associated Cervical Cancer.

  2021cites this paper
• Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients

  2021cites this paper
• Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

  2021cites this paper
• Oropharynxkarzinome: die Renaissance der Chirurgie?

  2021cites this paper
• Human Papillomavirus Associated Oropharyngeal Carcinoma-Diagnosis and Management

  2021cites this paper
• Characteristic differences in radiation‐induced DNA damage response in human papillomavirus‐negative and human papillomavirus‐positive head and neck cancers with accumulation of fractional radiation dose

  2021cites this paper
• Contemporary Opportunities in Nonsurgical Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• The tumor immune microenvironments of HPV+ and HPV- head and neck cancers.

  2021cites this paper
• Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV‐positive oropharynx cancer: Large‐scale comparison of DAHANCA vs PMH cohorts

  2021cites this paper
• Use of radiomics in the radiation oncology setting: Where do we stand and what do we need?

  2020cites this paper
• Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers

  2020cites this paper
• Factors influencing patient and health care delays in Oropharyngeal Cancer

  2020cites this paper
• Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions.

  2020cites this paper
• Biomarkers for immunotherapy response in head and neck cancer.

  2020cites this paper
• Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma

  2020cites this paper
• Improving five-year survival prediction via multitask learning across HPV-related cancers

  2020cites this paper
• CMAR_A_202465 5171..5185

  2019cites this paper
• Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.

  2019cites this paper
• Head and Neck Tumors

  2019cites this paper
• Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.

  2019cites this paper
• Acoustic Nanomotors for Detection of Human Papillomavirus–Associated Head and Neck Cancer

  2019cites this paper
• The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation

  2019cites this paper
• The Antiviral Agent Cidofovir Induces DNA Damage and Mitotic Catastrophe in HPV-Positive and -Negative Head and Neck Squamous Cell Carcinomas In Vitro

  2019cites this paper
• Neutrophils infiltration and its correlation with human papillomavirus status in the oral squamous cell carcinoma

  2019cites this paper
• Prognostic value of radiographically defined extranodal extension in human papillomavirus‐associated locally advanced oropharyngeal carcinoma

  2019cites this paper
• Advances in the Management of HPV-Related Oropharyngeal Cancer

  2019cites this paper
• Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response.

  2019cites this paper
• Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

  2019cites this paper
• Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery

  2018cites this paper
• Molecular Determinants of Head and Neck Cancer

  2018cites this paper
• A Review of HPV-Related Head and Neck Cancer

  2018cites this paper
• Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.

  2018cites this paper
• The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer.

  2018cites this paper
• Detection of HPV infection in head and neck cancers: Promise and pitfalls in the last ten years: A meta-analysis

  2018cites this paper
• Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.

  2018cites this paper
• The role of high-risk human papillomavirus in periocular cancers

  2018cites this paper
• HPV, hypoxia and radiation response in head and neck cancer.

  2018cites this paper
• Cáncer de Cabeza y Cuello asociado a Virus Papiloma Humano: Prevención, diagnóstico y tratamiento

  2018cites this paper
• The Clinical Impact of Hypoxia in Head and Neck Squamous Cell Carcinoma

  2018cites this paper
• Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?

  2018cites this paper
• Pushing the frontiers of radiobiology: a sPecial feature in memory of sir oliver scott and Professor Jack fowler: review article

  2018cites this paper
• Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study.

  2018cites this paper
• Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

  2018cites this paper
• Human papillomavirus prevalence and clinicopathological associations in oropharyngeal squamous cell carcinoma in the Lebanese population.

  2018cites this paper
• Human Papilloma Virus and Oral cancers: sexual behaviour as a risk factor

  2017cites this paper
• Role of Surgery in the Treatment of Oropharyngeal Squamous Cell Carcinoma: A Population-Based Review

  2017cites this paper
• Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland

  2017cites this paper
• Epidemiology and Molecular Biology of Head and Neck Cancer

  2017cites this paper
• The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.

  2017cites this paper
• Robotic Surgery plus Chemo-Radiation Therapy.

  2017cites this paper
• The association of human papillomavirus infection in indian cohort of head-and-neck squamous cell cancer patients and its impact on treatment outcome

  2017cites this paper
• Biomarkers and Radiotherapy

  2017cites this paper
• Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation

  2017cites this paper
• Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States

  2017cites this paper
• Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic Review.

  2017cites this paper
• Maintenance of head and neck tumor on-chip: gateway to personalized treatment?

  2017cites this paper
• 16 – Molecular Biology of Human Papillomavirus–Mediated Head and Neck Cancer

  2017cites this paper
• Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

  2017cites this paper
• Rethink radiotherapy – BIGART 2017

  2017cites this paper
• Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population‐based study

  2017cites this paper
• In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status

  2017cites this paper
• Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas

  2017cites this paper
• Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy

  2017cites this paper
• Human papillomavirus-related oropharyngeal cancer

  2017cites this paper
• Is Induction Chemotherapy Needed to Select Patients for Deintensified Treatment of Human Papillomavirus-Associated Oropharyngeal Cancer?

  2017cites this paper
• CXCR4: A New Player in an Old Scene?

  2017cites this paper
• SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.

  2017cites this paper
• HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

  2016cites this paper
• Human Papillomavirus in Head and Neck Cancer

  2016cites this paper
• Radiation-induced hypothyroidism after treatment of head and neck cancer.

  2016cites this paper
• Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy.

  2016cites this paper
• The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma

  2016cites this paper
• Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy

  2016cites this paper
• Radiation oncology in the era of precision medicine

  2016cites this paper
• Management of Oropharyngeal Cancer in the HPV Era.

  2016cites this paper
• Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.

  2016cites this paper
• Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma : An ASTRO Evidence Based Clinical Practice Guideline

  2016cites this paper